Mazurek Sybille, Boschek C Bruce, Hugo Ferdinand, Eigenbrodt Erich
Institute of Biochemistry & Endocrinology, Veterinary Faculty, University of Giessen, Frankfurter Strasse 100, 35392 Giessen, Germany.
Semin Cancer Biol. 2005 Aug;15(4):300-8. doi: 10.1016/j.semcancer.2005.04.009.
Proliferating cells and tumor cells in particular express the pyruvate kinase isoenzyme type M2 (M2-PK). Within the tumor metabolome M2-PK regulates the proportions of glucose carbons that are channelled to synthetic processes (inactive dimeric form) or used for glycolytic energy production (highly active tetrameric form, a component of the glycolytic enzyme complex). In tumor cells, the dimeric form of M2-PK (Tumor M2-PK) is always predominant. The dimerization is caused by direct interaction of M2-PK with certain oncoproteins. The switch between the tetrameric and dimeric form of M2-PK allows tumor cells to survive in environments with varying oxygen und nutrient supply.
增殖细胞尤其是肿瘤细胞表达丙酮酸激酶M2型同工酶(M2-PK)。在肿瘤代谢组中,M2-PK调节进入合成过程(无活性二聚体形式)或用于糖酵解能量产生(高活性四聚体形式,糖酵解酶复合物的一个组分)的葡萄糖碳的比例。在肿瘤细胞中,M2-PK的二聚体形式(肿瘤M2-PK)总是占主导地位。二聚化是由M2-PK与某些癌蛋白的直接相互作用引起的。M2-PK四聚体和二聚体形式之间的转换使肿瘤细胞能够在氧气和营养供应不同的环境中存活。